THERAPY OF ENDOCRINE DISEASE: Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues

Addition of Neutral Protamine Lispro Insulin or Insulin Glargine to Oral Type 2 Diabetes Regimens for Patients with Suboptimal Glycemic Control

(2013) Katherine Esposito   ANNALS OF INTERNAL MEDICINE

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control

(2013) Helena Rodbard et al.   Endocrine Practice

Riesgo de mortalidad en diabetes diagnosticada, diabetes no diagnosticada y prediabetes en población adulta española. Estudio Asturias 1998-2004

(2011) Sergio Valdés et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Importance of Postprandial Glucose Levels as a Target for Glycemic Control in Type 2 Diabetes

(2011) Joseph Tibaldi   SOUTHERN MEDICAL JOURNAL

Engaging and empowering patients to manage their type 2 diabetes, Part I: a knowledge, attitude, and practice gap?

(2010) Manuel Serrano-Gil et al.   ADVANCES IN THERAPY

Quantifying the duration of pre-diabetes

(2010) Melanie Y. Bertram et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH

Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes

(2010) A. Ringborg et al.   DIABETES & METABOLISM

Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial

(2010) M. C. Riddle et al.   DIABETES CARE

Correlates of Insulin Injection Omission

(2010) M. Peyrot et al.   DIABETES CARE

Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007*

(2010) C. J. Currie et al.   DIABETIC MEDICINE

Consensus guidelines, algorithms and care of the individual patient with type 2 diabetes

(2010) J. J. Nolan   DIABETOLOGIA

Intensified glucose lowering in type 2 diabetes: time for a reappraisal

(2010) J. S. Yudkin et al.   DIABETOLOGIA

Improved Glycemic Control with Insulin Glargine Versus Pioglitazone as Add-On Therapy to Sulfonylurea or Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus

(2010) Luigi Meneghini et al.   Endocrine Practice

Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study

(2010) Craig J Currie et al.   LANCET

Insulin Regimens in Type 2 Diabetes

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults

(2010) Elizabeth Selvin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Insulin initiation in primary care for patients with type 2 diabetes: 3-Year follow-up study

(2010) Jeremy Dale et al.   Primary Care Diabetes

Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: A meta-analysis

(2009) Jaime A. Davidson et al.   CLINICAL THERAPEUTICS

Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT

(2009) Krzysztof Strojek et al.   CURRENT MEDICAL RESEARCH AND OPINION

DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results: Safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes

(2009) J. B. Buse et al.   DIABETES CARE

Barriers to Insulin Injection Therapy

(2009) Richard R. Rubin et al.   DIABETES EDUCATOR

Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATETMstudy

(2009) L. Blonde et al.   DIABETES OBESITY & METABOLISM

Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study

(2009) M. J. Davies et al.   DIABETES OBESITY & METABOLISM

Step-up therapy with biphasic insulin aspart-70/30—Sapporo 1-2-3 study

(2009) N. Yoshioka et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses

(2009) D. S. Lasserson et al.   DIABETOLOGIA

Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes

(2009) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure

(2008) Yumi Miyashita et al.   Cardiovascular Diabetology

Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk

(2008) Tina Ken Schramm et al.   CIRCULATION

Good glycaemic control: an international perspective on bridging the gap between theory and practice in type 2 diabetes

(2008) E. S. Kilpatrick et al.   CURRENT MEDICAL RESEARCH AND OPINION

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2008) D. M. Nathan et al.   DIABETES CARE

Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study

(2008) F. Álvarez Guisasola et al.   DIABETES OBESITY & METABOLISM

Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study

(2008) J-F. Blicklé et al.   DIABETES OBESITY & METABOLISM

Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial

(2008) A. Liebl et al.   DIABETES OBESITY & METABOLISM

Long-acting insulin analogues versus NPH human insulin in type 2 diabetes

(2008) Matteo Monami et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Important differences: Canadian Diabetes Association 2008 clinical practice guidelines and the consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2008) V. Woo   DIABETOLOGIA

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

(2008) J. Rosenstock et al.   DIABETOLOGIA

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy

(2008) D. M. Nathan et al.   DIABETOLOGIA

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

(2008) Reinhard G Bretzel et al.   LANCET

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts)

(2007) P. Raskin et al.   DIABETES OBESITY & METABOLISM